PREVYMIS
PREVYMIS
Approved
DIN Number
02469367
Drug Class
Human
Market Date
Dec 20, 2017
Company
HC
Merck Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02469367
AIG Number0159630001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AX18 LETERMOVIR
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification08:18.08.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
LETERMOVIRActive
Strength: 20 MG / ML
Monograph: LETERMOVIR